Finance

Beta
Lists
PTX:ASX
Prescient Therapeutics Ltd
A$0,073
+1,39%
(+0,0010) 1D
5 ມິ.ຖ., 16 ໂມງ 10 ນາທີ 03 ວິນາທີ GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PTX...
Open
A$0,07
High
A$0,07
Low
A$0,07
Mkt. cap
໗໘,໙໕ ລ້ານ
Avg. vol.
໑,໐໗ ລ້ານ
Volume
໓໙໓,໕໗ ພັນ
52-wk high
A$0,12
52-wk low
A$0,04
EPS
A$-0,01
Shares outstanding
໑,໐໕ ຕື້
No. of employees
໓
Open
A$0,07
High
A$0,07
Low
A$0,07
Mkt. cap
໗໘,໙໕ ລ້ານ
Avg. vol.
໑,໐໗ ລ້ານ
Volume
໓໙໓,໕໗ ພັນ
52-wk high
A$0,12
52-wk low
A$0,04
EPS
A$-0,01
Shares outstanding
໑,໐໕ ຕື້
No. of employees
໓
News stories
From sources across the web
Profile
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
Founded22 ພ.ພ. 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
ມ.ນ. 2025
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
Revenue
1,55 ລ້ານ
1,55 ລ້ານ
578,89 ພັນ
578,89 ພັນ
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,51 ລ້ານ
2,51 ລ້ານ
1,24 ລ້ານ
1,24 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,35 ລ້ານ
1,35 ລ້ານ
1,13 ລ້ານ
1,13 ລ້ານ
Operating expense
4,02 ລ້ານ
4,02 ລ້ານ
2,57 ລ້ານ
2,57 ລ້ານ
Total operating expenses
4,02 ລ້ານ
4,02 ລ້ານ
2,57 ລ້ານ
2,57 ລ້ານ
Operating income
-2,46 ລ້ານ
-2,46 ລ້ານ
-1,99 ລ້ານ
-1,99 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-2,44 ລ້ານ
-2,44 ລ້ານ
-1,99 ລ້ານ
-1,99 ລ້ານ
EBT excluding unusual items
-2,44 ລ້ານ
-2,44 ລ້ານ
-1,99 ລ້ານ
-1,99 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,44 ລ້ານ
-2,44 ລ້ານ
-1,99 ລ້ານ
-1,99 ລ້ານ
Net profit margin
-156,80%
-156,80%
-344,35%
-344,35%
Earnings per share
-
-
-
-
Interest and investment income
20,29 ພັນ
20,29 ພັນ
1,86 ພັນ
1,86 ພັນ
Interest expense
-
-
-2,97 ພັນ
-2,97 ພັນ
Net interest expenses
20,29 ພັນ
20,29 ພັນ
-1,12 ພັນ
-1,12 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,46 ລ້ານ
-2,46 ລ້ານ
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer